Python has made using Microsoft Excel much easier than it has ever been, and it isn't very hard to start using it yourself.

Transition from user to developer through consistent notation, table-based architecture, global constants, and ...

Anthropic upgraded Claude’s Excel and PowerPoint add-ins with shared context, reusable Skills, and cross-app workflows for business users.

Anthropic announced a series of Claude-connected updates on Wednesday aimed at improving the workflows of Microsoft 365 users. The deep integration between the tools is designed to save time and ...

NASA Administrator Jared Isaacman announced sweeping changes to the Artemis program on Friday morning, including an increased cadence of missions and cancellation of an expensive rocket stage. The ...

New laptops with ARM processors (such as some Surface models) run older software through an emulation layer, which can cause Power Query to crash. Installing the native ARM64 version of Office allows ...

This story is sponsored by Utah Tech Online. In today's job market, clear and strategic communication isn't just a bonus skill — it's a necessity. Companies are looking for people who can simplify ...

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes the ...

The romance industry, always at the vanguard of technological change, is rapidly adapting to A.I. Not everyone is on board. By Alexandra Alter Last February, the writer Coral Hart launched an ...

Starting in autumn quarter 2025, the University will begin a multi-year restructuring of the undergraduate writing program, which had previously run concurrently with the humanities Core sequence.

Courtney Peña-Lima is an associate director at the Biosciences Grant Writing Academy at Stanford University in California and a writing instructor at the Stanford University School of Medicine. Troy ...

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene-writing program, inking a deal that lets it in on a prospect for alpha-1 antitrypsin deficiency (AATD) through a $150 million ...